Effects of the mixed-action κ/μ opioid agonist 8-carboxamidocyclazocine on cocaine- and food-maintained responding in rhesus monkeys

European Journal of Pharmacology

Volumn 506, Issue 2, 2004, Pages 133-141

  Stevenson, Glenn W ^a   Wentland, Mark P ^b   Bidlack, Jean M ^c   Mello, Nancy K ^a   Negus, S Stevens ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Research Rensselaer Polytechnic Institute   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

8 Carboxamidocyclazocine; Cocaine; Drug self administration; Kappa agonist; Monkey; rhesus

Indexed keywords

8 CARBOXAMIDOCYCLAZOCINE; COCAINE; CYCLAZOCINE; KAPPA OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SCREENING; DRUG SELF ADMINISTRATION; DRUG TOLERANCE; FEMALE; FOOD INTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALS; COCAINE; CONDITIONING, OPERANT; CYCLAZOCINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOOD; HYPNOTICS AND SEDATIVES; MACACA MULATTA; MALE; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; REINFORCEMENT SCHEDULE; REWARD; VOMITING;

EID: 9944237874     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.10.051     Document Type: Article

References (24)

1. J.M. Bidlack, D.J. Cohen, J.P. McLaughlin, R. Lou, Y. Ye, and M.P. Wentland 8-Carboxamidocyclazocine: a long-acting, novel benzomorphan J. Pharmacol. Exp. Ther. 302 2002 374 380
2. C.A. Bowen, S.S. Negus, R. Zong, J.L. Neumeyer, J.M. Bidlack, and N.K. Mello Effects of mixed-action kappa/mu opioids on cocaine self-administration and cocaine discrimination by rhesus monkeys Neuropsychopharmacology 28 2003 1125 1139
3. D.P. Devine, P. Leone, D. Pocock, and R.A. Wise Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies J. Pharmacol. Exp. Ther. 266 1993 1236 1246
4. G. Di Chiara, and A. Imperato Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats Proc. Natl. Acad. Sci. U. S. A. 85 1988 5274 5278
5. M.B. Gatch, S.S. Negus, N.K. Mello, S. Archer, and J.M. Bidlack Effects of the structurally novel opioid 14 alpha, 14′ beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys J. Pharmacol. Exp. Ther. 278 1996 1282 1289
6. S.D. Glick, I.M. Maisonneuve, J. Raucci, and S. Archer Kappa opioid inhibition of morphine and cocaine self-administration in rats Brain Res. 681 1995 147 152
7. R.A. Greenstein, P.J. Fudala, and P. Obrien Alternative pharmacotherapies for opiate addiction J. Lowinson P. Ruiz R.B. Millman J.G. Langrod Substance Abuse: A Comprehensive Textbook 1997 Williams and Wilkins Baltimore 415 425
8. R.G. Heath, A.T. Fitzjarrell, and C.F. Walker Kappa opiate receptor agonists: effects on behavior and on brain function and structure in rhesus monkeys Biol. Psychiatry 19 1984 1045 1074
9. J.L. Katz, and S.R. Goldberg Effects of ethylketazocine and morphine on schedule-controlled behavior in pigeons and squirrel monkeys J. Pharmacol. Exp. Ther. 239 1986 433 441
10. H.D. Kleber Pharmacologic treatments for heroin and cocaine dependence Am. J. Addict. 12 Suppl. 2 2003 S5 S18
11. J.H. Lowinson, J.T. Payte, E. Salsitz, H. Joseph, I.J. Marion, and V.P. Dole Methadone maintenance J. Lowinson P. Ruiz R.B. Millman J.G. Langrod Substance Abuse: A Comprehensive Textbook 1997 Williams and Wilkins Baltimore 405 415
12. I.M. Maisonneuve, S. Archer, and S.D. Glick U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats Neurosci. Lett. 181 1994 57 60
13. N.K. Mello, and S.S. Negus Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures Neuropsychopharmacology 14 1996 375 424
14. N.K. Mello, and S.S. Negus Effects of kappa opioid agonists on cocaine- and food-maintained responding by rhesus monkeys J. Pharmacol. Exp. Ther. 286 1998 812 824
15. N.K. Mello, and S.S. Negus Interactions between kappa opioid agonists and cocaine. Preclinical studies Ann. N.Y. Acad. Sci. 909 2000 104 132
16. J.H. Mendelson, and N.K. Mello Management of cocaine abuse and dependence N. Engl. J. Med. 334 1996 965 972
17. S.S. Negus, T.F. Burke, F. Medzihradsky, and J.H. Woods Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine J. Pharmacol. Exp. Ther. 267 1993 896 903
18. S.S. Negus, N.K. Mello, P.S. Portoghese, and C.E. Lin Effects of kappa opioids on cocaine self-administration by rhesus monkeys J. Pharmacol. Exp. Ther. 282 1997 44 55
19. NIDA Epidemiologic trends in drug abuse NIH Publication No. 00-4739A 2000 99
20. A. Pfeiffer, V. Brantl, A. Herz, and H.M. Emrich Psychotomimesis mediated by kappa opiate receptors Science 233 1986 774 776
21. R.L. Richmond, K. Harris, and A. de Almeida Neto The transdermal nicotine patch: results of a randomised placebo-controlled trial Med. J. Aust. 161 1994 130 135
22. S. Schenk, B. Partridge, and T.S. Shippenberg U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking Psychopharmacology (Berl.) 144 1999 339 346
23. S.L. Walsh, E.C. Strain, M.E. Abreu, and G.E. Bigelow Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans Psychopharmacology (Berl.) 157 2001 151 162
24. M.P. Wentland, R. Lou, Y. Ye, D.J. Cohen, G.P. Richardson, and J.M. Bidlack 8-Carboxamidocyclazocine analogues: redefining the structure-activity relationships of 2,6-methano-3-benzazocines Bioorg. Med. Chem. Lett. 11 2001 623 626